Literature DB >> 31251335

Analysis of Genetic Association of Intestinal Permeability in Healthy First-degree Relatives of Patients with Crohn's Disease.

Williams Turpin1,2, Osvaldo Espin-Garcia3, Larbi Bedrani2, Karen Madsen4, Jonathan B Meddings5, Juan Antonio Raygoza Garay2, Mark S Silverberg1, Michelle I Smith1,2, Anne M Griffiths6, Paul Moayyedi7, John K Marshall7, David Mack8, Ernest G Seidman9, Mark Ropeleski10, Brian G Feagan11, Kevan Jacobson12, Dan Turner13, Thomas Walters6, Andrew D Paterson3,14, Wei Xu3, Kenneth Croitoru1,2.   

Abstract

Excessive intestinal permeability or intestinal barrier dysfunction as measured by various assays has been observed in various diseases. However, little is known about the factors contributing to altered gut permeability in these diseases. Our objective was to determine the genetic determinants of altered gut permeability as measured by the lactulose mannitol fractional excretion ratio (LacMan ratio) in 1075 healthy first-degree relatives of patients with Crohn's disease (CD). In a targeted analysis of single nucleotide polymorphisms (SNPs) located in genes associated with intestinal barrier function related or not to inflammatory bowel disease, we did not find a significant association with intestinal permeability. In an untargeted genome-wide association analysis, the top 100 associations were located in 22 genomic loci, although they were not statistically significant after correction for multiple testing (raw P values [1.8 × 10-7 - 1.4 × 10-5]. The lowest P value was obtained for rs9616637 (22q13.33, C22orf34), for which the minor allele A was associated with a decreased LacMan ratio. These results suggest that host genetic background has limited contribution toward intestinal permeability. Despite this, our study is currently the largest of its kind assessing gut permeability in vivo. It remains possible that smaller genetic effect sizes on LacMan ratio are not detectable in this sized cohort. Larger studies are warranted to identify the potential genetic contribution to intestinal permeability.
© 2019 Crohn’s & Colitis Foundation. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  GWAS; LacMan; biomarker; intestinal barrier; leaky gut

Mesh:

Substances:

Year:  2019        PMID: 31251335     DOI: 10.1093/ibd/izz116

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  8 in total

Review 1.  Manipulation of Gut Microbiota as a Key Target for Crohn's Disease.

Authors:  Reem Rashed; Rosica Valcheva; Levinus A Dieleman
Journal:  Front Med (Lausanne)       Date:  2022-06-16

Review 2.  Multiomics to elucidate inflammatory bowel disease risk factors and pathways.

Authors:  Manasi Agrawal; Kristine H Allin; Francesca Petralia; Jean-Frederic Colombel; Tine Jess
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2022-03-17       Impact factor: 73.082

3.  Electrophysiologic Analysis of Tight Junction Size and Charge Selectivity.

Authors:  Nitesh Shashikanth; Heather E Rizzo; Pawin Pongkorpsakol; John F Heneghan; Jerrold R Turner
Journal:  Curr Protoc       Date:  2021-06

Review 4.  The Effectiveness of Probiotics in the Treatment of Inflammatory Bowel Disease (IBD)-A Critical Review.

Authors:  Dominika Jakubczyk; Katarzyna Leszczyńska; Sabina Górska
Journal:  Nutrients       Date:  2020-07-02       Impact factor: 5.717

5.  Serum Zonulin Measured by Commercial Kit Fails to Correlate With Physiologic Measures of Altered Gut Permeability in First Degree Relatives of Crohn's Disease Patients.

Authors:  Namita Power; Williams Turpin; Osvaldo Espin-Garcia; Michelle I Smith; Kenneth Croitoru
Journal:  Front Physiol       Date:  2021-03-25       Impact factor: 4.566

6.  Ruscogenins Improve CD-Like Enteritis by Inhibiting Apoptosis of Intestinal Epithelial Cells and Activating Nrf2/NQO1 Pathway.

Authors:  Hexin Wen; Xiaofeng Zhang; Qingqing Li; Ju Huang; Guangyong Liu; Jingyue Zhao; Yiran Liu; Li Shen; Yuyang Li; Kun Yang; Lugen Zuo; Jing Li; Jing Nian; Ping Xiang; Hao Zhao; Liang Yu; Mulin Liu; Zhijun Geng; Xue Song
Journal:  Oxid Med Cell Longev       Date:  2022-03-10       Impact factor: 6.543

7.  Spp24 is associated with endocytic signalling, lipid metabolism, and discrimination of tissue integrity for 'leaky-gut' in inflammatory bowel disease.

Authors:  Valerie C Wasinger; Kenneth Lu; Yunki Y Yau; Justin Nash; Jess Lee; Jeff Chang; Sudarshan Paramsothy; Nadeem O Kaakoush; Hazel M Mitchell; Rupert W L Leong
Journal:  Sci Rep       Date:  2020-07-31       Impact factor: 4.379

Review 8.  Gut Microbial Metabolite-Mediated Regulation of the Intestinal Barrier in the Pathogenesis of Inflammatory Bowel Disease.

Authors:  Namrata Iyer; Sinéad C Corr
Journal:  Nutrients       Date:  2021-11-26       Impact factor: 5.717

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.